Answers are grounded in this paper and cite their sources.
Membrane blebbing: the transient, pressure-driven protrusion of the plasma membrane away from the underlying actomyosin cortex, has evolved from a curiosity of apoptotic morphology into a central theme in cell migration, mechanotransduction and intercellular signalling. Blebs enable amoeboid motility in confined tissues, act as oncogenic signalling hubs that confer resistance to anoikis, and are now recognized as the biogenic origin of a remarkable class of large, organelle-rich extracellular vesicles termed blebbisomes. Capturing these fast, three-dimensional and biochemically heterogeneous events in living cells demands imaging reporters that are photostable, minimally perturbing and selective for the molecular machinery that builds and dismantles blebs. Here we review the chemistry and cell biology of fluorescent probes for visualizing blebbing dynamics and the vesicular communication that blebbing supports. We first summarize the mechanochemical life cycle of a bleb and the biological contexts, apoptosis, cytokinesis, amoeboid invasion and vesicle shedding, in which blebbing matters. We then survey the fluorescent toolkit, from genetically encoded actin reporters and fluorogenic cytoskeletal stains (SiR/SPY dyes) to environment-sensitive solvatochromic membrane probes, emphasizing the photophysical criteria that govern their success in fast live-cell imaging. As an illustrative case study, we examine a recently reported family of targeted small-molecule reporters (the AztecBleb probes) that exploit a pregnenolone/abiraterone-derived scaffold to localize to blebs and microtubule plus-ends through the plus-end tracking protein CLIP-170, providing persistent, multichannel and actin-independent staining of blebs. We connect single-cell blebbing imaging to the emerging biology of blebbisomes and other blebbing-derived vesicles that ferry mitochondria, RNA and immune-checkpoint proteins between cells, and we discuss how probe-enabled visualization intersects with biosensor and liquid-biopsy technologies for translational deployment. We close by outlining the outstanding chemical and biological challenges, selectivity, quantitation, in vivo compatibility and clinical validation, that must be met to move blebbing-selective reporters from the confocal bench toward diagnostic and therapeutic impact.
No takes yet. Share an insight, caveat, or question.
Cortes‐Muñoz et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: